Breakthrough Peptide Healing: How BPC 157 & TB 500 Support Rapid Recovery at Iowa IV Iowa IV The Human Lab Rats Injecting Themselves with Peptides Office for Science and Society McGill University BPC 157 Dosing (Common Protocols) Oral Subcutaneous 500 mcg daily Duration: 6 weeks Intramuscular Peritendinous 1 mg daily Duration: 6 weeks Note: Not approved Is BPC 157 Banned? Oral vs. Injectable Forms Explained These two peptides are often discussed together but they are studied for different biological roles. BPC 157 is commonly mentioned in research related to localized tissue repair and gut lining signaling pathways. TB 500